Hyderabad Telangana, India

Sandeep Kumar Vadla

This inventor holds 1 USPTO granted patent. Top assignee: Aurobindo Pharma Limited. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sandeep Kumar Vadla: Innovator in Pharmaceutical Chemistry

Introduction

Sandeep Kumar Vadla is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for drug preparation. His work is characterized by a commitment to advancing medical science through innovative solutions.

Latest Patents

Sandeep Kumar Vadla holds a patent for a process titled "Process for the preparation of trametinib acetic acid solvate." This invention relates to a method for preparing Trametinib acetic acid solvate, which is crucial for pharmaceutical applications. The patent also encompasses a pharmaceutical composition that includes Trametinib acetic acid solvate and may contain one or more pharmaceutically acceptable excipients or carriers. He has 1 patent to his name.

Career Highlights

Sandeep Kumar Vadla is currently employed at Aurobindo Pharma Limited, a prominent player in the pharmaceutical industry. His role at the company allows him to apply his expertise in drug formulation and development, contributing to the advancement of healthcare solutions.

Collaborations

Throughout his career, Sandeep has collaborated with several professionals in the field. Notable coworkers include Venkata Rama Krishna Murthy Moturu and Ramadas Chavakula, who have worked alongside him in various projects.

Conclusion

Sandeep Kumar Vadla's contributions to pharmaceutical chemistry exemplify the impact of innovation in healthcare. His patent for Trametinib acetic acid solvate highlights his dedication to improving drug formulation processes. His work continues to inspire advancements in the pharmaceutical industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…